Vertex Pharmaceuticals Incorporated company logo
Vertex Pharmaceuticals Incorporated logo

VRTX Depreciation & Amortization

Annual D&A

$207.20M$37.70M+22.24%

Summary

Current Value
As of today, VRTX annual D&A is $207.20M, up +22.24% on
Historical Performance
VRTX annual D&A is up +64.97% over the past 3 years, and up +93.75% over the past 5 years
All-Time High Comparison
VRTX annual D&A is currently at its all-time high
3-Year Low Comparison
VRTX annual D&A is +39.72% above its 3-year low of $148.30M reached on an earlier date
Sector Comparison
VRTX annual D&A is higher than 92.05% of companies in Healthcare sector

Depreciation & Amortization Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

VRTX Performance
MetricDateValue1Y3Y5Y15Y
Annual D&A$207.20M+22.2%+65.0%+93.8%+588.2%
Quarterly D&A$54.00M+1.5%+47.1%+102.7%+699.0%
TTM D&A$200.60M-3.5%+39.6%+88.5%+554.8%
Price$454.67+10.0%+51.1%+100.2%+1079.4%
Annual SG&A$1.46B+28.8%+74.3%+122.4%+1024.7%
Annual Total Expenses$6.63B+19.1%+38.2%+123.8%+853.7%
Annual Operating Expenses$5.09B+18.5%+30.9%+111.1%+648.7%
Annual Revenue$10.98B+11.6%+44.5%+165.9%+10000.0%

Depreciation & Amortization Highs

VRTX Annual D&A Highs Comparison
PeriodHighDateCurrent
3Y$207.20Mat high
5Y$207.20Mat high
All$207.20Mat high

Depreciation & Amortization Lows

VRTX Annual D&A Lows Comparison
PeriodLowDateCurrent
3Y$148.30MN/A+39.7%
5Y$109.52MN/A+89.2%
All$1.83M>+9999.0%

Depreciation & Amortization History

YearValueChange
$207.20M+22.2%
$169.50M+14.3%
$148.30M+18.1%
$125.60M+14.7%
$109.52M+2.4%
$106.94M+47.7%
$72.42M+18.0%
$61.40M-0.0%
$61.40M-1.5%
$62.34M-1.4%
$63.26M+30.8%
$48.37M+26.6%
$38.19M+9.0%
$35.04M+15.0%
$30.46M+1.2%
$30.11M-6.5%
$32.20M+17.3%
YearValueChange
$27.46M+6.2%
$25.87M-5.2%
$27.29M-7.9%
$29.64M+26.5%
$23.44M-7.8%
$25.43M+41.6%
$17.96M+97.5%
$9.10M+46.6%
$6.21M+37.3%
$4.52M+26.0%
$3.59M+13.5%
$3.16M-14.8%
$3.71M+6.5%
$3.49M-10.6%
$3.90M+40.5%
$2.77M+51.8%
$1.83M-

FAQ

  • What is the current annual D&A of VRTX?

    As of today, VRTX annual D&A is $207.20M

  • What is 1-year change in VRTX annual D&A?

    VRTX annual D&A is up +22.24% year-over-year

  • What is 3-year change in VRTX annual D&A?

    VRTX annual D&A is up +64.97% over the past 3 years

  • How far is VRTX annual D&A from its all-time high?

    VRTX annual D&A is currently at its all-time high

  • How does VRTX annual D&A rank versus sector peers?

    VRTX annual D&A is higher than 92.05% of companies in Healthcare sector

  • When is VRTX next annual earnings release?

    The next annual earnings release for VRTX is on

Data Sources & References

  1. VRTX Official Website www.vrtx.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/875320/000087532025000232/0000875320-25-000232-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/875320/000087532025000053/0000875320-25-000053-index.htm
  4. VRTX Profile on Yahoo Finance finance.yahoo.com/quote/VRTX
  5. VRTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrtx